Prognostic role of 11C‐choline PET/CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapy-Reference-Cited by-同舟云学术

Prognostic role of 11C‐choline PET/CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapy

Published:2021-10-11 Issue:1 Volume:82 Page:41-48
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Jimbo Masaya¹^ORCID,Andrews Jack R.¹^ORCID,Ahmed Mohamed E.¹^ORCID,Dundar Ayca²^ORCID,Karnes R. Jeffrey¹,Bryce Alan H.³,Kendi Ayse T.²,Kwon Eugene D.¹,Lowe Val J.²,Bold Michael S.²

Affiliation:

1. Department of Urology Mayo Clinic Rochester Minnesota USA

2. Department of Radiology Mayo Clinic Rochester Minnesota USA

3. Division of Hematology and Medical Oncology, Department of Internal Medicine Mayo Clinic Phoenix Arizona USA

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24246

Reference40 articles.

1. Cancer statistics, 2019

2. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States

3. A history of prostate cancer treatment

4. Overcoming docetaxel resistance in prostate cancer: a perspective review

5. Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?;Seminars in Nuclear Medicine;2024-01

2. Les radiotraceurs autres que le PSMA-ligand pour l’imagerie TEP du cancer de prostate;Médecine Nucléaire;2023-10

3. Clinical advancement of precision theranostics in prostate cancer;Frontiers in Oncology;2023-02-02